Biosimilars in Oncology: Latest Trends and Regulatory Status
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14122721
Abstract: Biologic-based medicines are used to treat a variety of diseases and account for around one-quarter of the worldwide pharmaceutical market. The use of biologic medications among cancer patients has resulted in substantial advancements in cancer… read more here.
Keywords: biosimilars oncology; oncology; oncology latest; latest trends ... See more keywords